A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies (Q33348948)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies |
scientific article |
Statements
1 reference
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies (English)
1 reference
Mitchell A Garrison
1 reference
Lisa A Hammond
1 reference
Charles E Geyer
1 reference
Garry Schwartz
1 reference
Anthony W Tolcher
1 reference
Leslie Smetzer
1 reference
Jose A Figueroa
1 reference
Murray Ducharme
1 reference
John Coyle
1 reference
Chris H Takimoto
1 reference
Robert L De Jager
1 reference
Eric K Rowinsky
1 reference
1 July 2003
1 reference
1 reference
2527-2537
1 reference
Identifiers
1 reference